Literature DB >> 29708155

Guidelines for stereotactic body radiation therapy treatment of lung cancer highlight important research questions: what is the next step?

Lorraine D Cornwell1, Melissa L Korb2, Bryan M Burt2.   

Abstract

Entities:  

Year:  2018        PMID： 29708155      PMCID： PMC5906265          DOI： 10.21037/jtd.2018.03.36

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  11 in total

1.  Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small-cell lung cancer: five-year mature results.

Authors:  Yuta Shibamoto; Chisa Hashizume; Fumiya Baba; Shiho Ayakawa; Akifumi Miyakawa; Taro Murai; Taiki Takaoka; Yukiko Hattori; Ryuji Asai
Journal:  J Thorac Oncol       Date:  2015-06       Impact factor: 15.609

2.  A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.

Authors:  Babatunde A Yerokun; Chi-Fu Jeffrey Yang; Brian C Gulack; Xuechan Li; Michael S Mulvihill; Lin Gu; Xiaofei Wang; David H Harpole; Thomas A D'Amico; Mark F Berry; Matthew G Hartwig
Journal:  J Thorac Cardiovasc Surg       Date:  2017-04-04       Impact factor: 5.209

3.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Authors:  Frank J Lagerwaard; Naomi E Verstegen; Cornelis J A Haasbeek; Ben J Slotman; Marinus A Paul; Egbert F Smit; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-19       Impact factor: 7.038

4.  Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.

Authors:  Gregory M M Videtic; Jessica Donington; Meredith Giuliani; John Heinzerling; Tomer Z Karas; Chris R Kelsey; Brian E Lally; Karen Latzka; Simon S Lo; Drew Moghanaki; Benjamin Movsas; Andreas Rimner; Michael Roach; George Rodrigues; Shervin M Shirvani; Charles B Simone; Robert Timmerman; Megan E Daly
Journal:  Pract Radiat Oncol       Date:  2017-06-05

5.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

6.  Changes in Treatment Patterns and Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer in the United States After the Incorporation of Stereotactic Ablative Radiation Therapy: A Population-based Analysis.

Authors:  Waqar Haque; Sean Szeja; Anne Tann; Sarathi Kalra; Bin S Teh
Journal:  Am J Clin Oncol       Date:  2018-03       Impact factor: 2.339

7.  Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.

Authors:  Lorraine D Cornwell; Alfredo E Echeverria; Jason Samuelian; Jessica Mayor; Roberto F Casal; Faisal G Bakaeen; Shuab Omer; Ourania Preventza; Weiyuan Mai; George Chen; Katherine H Simpson; Drew Moghanaki; Angela W Zhu
Journal:  J Thorac Cardiovasc Surg       Date:  2017-08-16       Impact factor: 5.209

8.  Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.

Authors:  Bryan J Schneider; Megan E Daly; Erin B Kennedy; Mara B Antonoff; Stephen Broderick; Jill Feldman; Shruti Jolly; Bryan Meyers; Gaetano Rocco; Chad Rusthoven; Ben J Slotman; Daniel H Sterman; Brendon M Stiles
Journal:  J Clin Oncol       Date:  2017-11-06       Impact factor: 44.544

9.  Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.

Authors:  Takahisa Eriguchi; Atsuya Takeda; Naoko Sanuki; Yuichiro Tsurugai; Yousuke Aoki; Yohei Oku; Yu Hara; Takeshi Akiba; Naoyuki Shigematsu
Journal:  Lung Cancer       Date:  2017-05-04       Impact factor: 5.705

10.  Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.

Authors:  Yasushi Nagata; Masahiro Hiraoka; Taro Shibata; Hiroshi Onishi; Masaki Kokubo; Katsuyuki Karasawa; Yoshiyuki Shioyama; Rikiya Onimaru; Takuyo Kozuka; Etsuo Kunieda; Tsutomu Saito; Keiichi Nakagawa; Masato Hareyama; Yoshihiro Takai; Kazushige Hayakawa; Norio Mitsuhashi; Satoshi Ishikura
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-11       Impact factor: 7.038
View more
  1 in total

1.  Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes.

Authors:  Felix-Nikolai Oschinka Jegor Habermann; Daniela Schmitt; Thomas Failing; Jann Fischer; David Alexander Ziegler; Laura Anna Fischer; Niklas Josua Alt; Julian Muster; Sandra Donath; Andrea Hille; Markus Anton Schirmer; Manuel Guhlich; Rami A El Shafie; Stefan Rieken; Martin Leu; Leif Hendrik Dröge
Journal:  Curr Oncol       Date:  2022-02-13       Impact factor: 3.677
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.